Join the Fight Against MDS
Every gift helps patients, caregivers, and healthcare professionals access life-saving resources, support, and education. Together, we can make a difference. Even a small contribution can create a big impact. Thank you for your generosity.
July 18, 2020
Low-Risk MDS: Can we prevent progression?
Low-Risk MDS: Can we prevent progression?
This webinar will provide an overview summarizing changes in the treatment landscape for patients with low-risk myelodysplastic syndromes. The concerns of low-risk MDS patients and their caregivers will be addressed.
Speaker
CO
Casey L. O’Connell, MD
Outputs
Access to the meeting outputs are available below by clicking on each topic.
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, and Acceleron for supporting this initiative.
